Inhibition of interleukin-6 by tocilizumab improves endothelial glycocalyx and myocardial work index in patients with rheumatoid arthritis

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by